The KINE SCIENCES homepage is a valuable asset owned exclusively by KINE SCIENCES at all costs, and copyrights for all of them also belong to KINE SCIENCES. We are informing you of some legal notices regarding the use of the KINE SCIENCES website, so please be aware of this and make sure that you are not mistaken about using the website Please give us encouragement and support for our daunting journey. Patients and their families better, and ultimately improving well-being of humanity byĭeveloping safer, more economical and more convenient medicines of ultra small KINE SCIENCES is committed to treating chronic immune diseases, making lives of These diseases put a great burden not only on patients themselves but their families Make lifelong treatment of expensive medicines inevitable for patients. On the market than any other era of human history, we humans have yet to find curesįor these chronic immune diseases by seeing occurrence of resistance or relapse which Though we live in an era when we see more research on life sciences and more drugs Inflammatory bowel diseases, atopic dermatitis, psoriasis, cancer, Alzheimer’s disease, The diseases we aim to treat are chronic immune diseases such as rheumatoid arthritis, We discovered the function of a novel cytokine ERDR1 for the first time in the worldĪnd since we have been developing drug candidates of ultra-small peptide with privateĪnd public funding including the one from Korea Drug Development Fund for KINE SCIENCES is a company that develops ultra-small peptide innovative medicines
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |